Sitemap

Report

Foreword

Overall trends and developments

Trends in the drug situation

Cannabis  |  Amphetamines and ecstasy (MDMA)  |  Cocaine and crack cocaine  |  Heroin and injecting drug use  |  Human immunodeficiency virus (HIV), hepatitis C (HCV) and hepatitis B (HBV)  |  Overdoses

Developments in responses to drug use

EU policy  |  Member States’ policies  |  Interventions  |  Quality assurance

Chapter 1: Drug situation

Drug use in the general population

Prevalence and patterns of drug use in the general population  |  Trends in drug use among the general population

Problem drug use

Demand for treatment

Substances  |  Trends  |  Patterns of use and routes of administration  |  Social characteristics

Drug-related infectious diseases

Prevalence and trends in HIV and AIDS  |  Prevalence of and trends in hepatitis C virus infection  |  Prevalence of and trends in hepatitis B virus infection  |  Notified cases of hepatitis B and C

Drug-related deaths and mortality among drug users

Impact of drug-related deaths  |  Risk factors  |  Characteristics of victims  |  Deaths due to substances other than opiates  |  Trends in acute drug-related deaths  |  Overall mortality among problem drug users  |  Trends in mortality among problem drug users

Drug-related crime

Drug law offences  |  Drug users in the criminal justice system: prisoners

Drug markets and availability

Cannabis  |  Heroin  |  Cocaine  |  Synthetic drugs: amphetamines, ecstasy and LSD

Chapter 2: Responses to drug use

National drug policy developments

Reorganisation in drug coordination systems  |  Public perception of drugs and drug policy

Legal developments

Treatment and rehabilitation  |  Monitoring of traffickers  |  Measures to reduce public order/nuisance offences

Developments at EU level

Prevention

Harm-reduction responses

Prevention of infectious diseases  |  Reducing drug-related deaths

Treatment

Medically assisted treatment  |  Drug-free treatment  |  Standards and quality of treatment

Responses targeting drug users in criminal justice settings

Policy framework  |  Prison-based psychosocial and health interventions  |  Alternatives to incarceration

Supply reduction

Interdiction measures  |  Anti-money laundering measures  |  Measures against diversion of chemicals under control

Chapter 3: Selected issues

Drug and alcohol use among young people

Prevalence, attitudes and trends  |  Initiation, patterns and risk factors  |  Deaths and hospital emergencies  |  Legal responses and recommendations  |  A broad continuum of needs and responses

Social exclusion and reintegration

Definitions and concepts  |  Drug-use patterns and consequences observed among socially excluded populations  |  Relationship between social exclusion and drug use  |  Social reintegration

Public expenditure in the area of drug-demand reduction

Limitation and reliability of data  |  Expenditure in drug-demand reduction  |  Repartition of expenditure  |  Final considerations

Legal notice

Acknowledgements

Data library

Data library

Data elements by theme

Drug use in the general population  |  Problem drug use  |  Demand for treatment  |  Drug-related infectious diseases  |  Drug-related deaths and mortality among drug users  |  Drug-related crime  |  Drug markets and availability  |  Prevention  |  Harm reduction responses  |  Treatment  |  Responses targeting drug users in criminal justice settings  |  Supply reduction  |  Drug and alcohol use among young people  |  Social exclusion and reintegration  |  Public expenditure in the area of drug demand reduction

Data elements by category

Figures  |  Boxes  |  Tables  |  Statistical tables

Reitox national reports

References

Press point

Press point

2003 ANNUAL REPORT ON THE DRUG SITUATION IN THE EU & NORWAY

Some ‘cautious optimism’ but beware of complacency, warns agency

EMCDDA 2003 ANNUAL REPORTS: SPECIAL FOCUS ON YOUNG PEOPLE

Rising concern about ‘binge’ drinking and intensive drug use among the young and vulnerable

Downloads

Printed version

About…

About the EMCDDA